Retrieved August 30, 2014
For M&A diligence on an ADC-focused company, the acquirer must assess not only which ADC programs are covered by in-house patents but also which in-licensed linker and payload platform patents are material, whether those licenses are transferable in the transaction, and whether there are third-party patents covering the specific antibody-target combination at issue
Review contraindications against your own history: Medullary thyroid carcinoma family history, MEN 2 syndrome, pancreatitis history, severe GI or kidney disease, pregnancy, breastfeeding - if any of these apply, discuss with your own physician before starting the intake
The documented route is subcutaneous a shallow injection into the fat layer just under the skin (abdomen, flank or thigh), using a fine insulin needle
Average weight loss of 15-20% body weight in clinical trialsresults previously only achievable through surgery
Whillier et al., 2009